6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.

Fricke I, Viel T, Worlitzer M, Collmann F, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann M, Schäfers K, Hermann S, Schwamborn J, Jacobs A.

Research article (journal) | Peer reviewed

Abstract

Parkinson's disease is a slowly progressing neurodegenerative disorder caused by loss of dopaminergic neurons in the substantia nigra (SN), leading to severe impairment in motor and non-motor functions. Endogenous subventricular zone (SVZ) neural stem cells constantly give birth to new cells that might serve as a possible source for regeneration in the adult brain. However, neurodegeneration is accompanied by neuroinflammation and dopamine depletion, potentially compromising regeneration. We therefore employed in vivo imaging methods to study striatal deafferentation (N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane single photon emission computed tomography, DaTscan™) and neuroinflammation in the SN and striatum (N,N-diethyl-2-(2-(4-(2-[18F]fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide positron emission tomography, [18F]DPA-714 PET) in the intranigral 6-hydroxydopamine Parkinson's disease mouse model. Additionally, we transduced cells in the SVZ with a lentivirus encoding firefly luciferase and followed migration of progenitor cells in the SVZ-olfactory bulb axis via bioluminescence imaging under disease and control conditions. We found that activation of microglia in the SN is an acute process accompanying the degeneration of dopaminergic cell bodies in the SN. Dopaminergic deafferentation of the striatum does not influence the generation of doublecortin-positive neuroblasts in the SVZ, but generates chronic astrogliosis in the nigrostriatal system.

Details about the publication

JournalEuropean Journal of Neuroscience (Eur. J. Neurosci.)
Volume43
Issue10
Page range1352-1365
StatusPublished
Release year2016
Language in which the publication is writtenEnglish
DOI10.1111/ejn.13232
Link to the full texthttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84963670063&origin=inward
Keywords6-hydroxydopamine; Mouse; Neuroinflammation; Parkinson's disease; [18F]DPA-714

Authors from the University of Münster

Faber, Cornelius Joachim
Clinic of Radiology
Faust, Andreas
European Institute of Molecular Imaging (EIMI)
Fricke, Inga
European Institute of Molecular Imaging (EIMI)
Hermann, Sven
European Institute of Molecular Imaging (EIMI)
Jacobs, Andreas Hans
European Institute of Molecular Imaging (EIMI)
Kuhlmann, Michael
European Institute of Molecular Imaging (EIMI)
Schäfers, Klaus
European Institute of Molecular Imaging (EIMI)
Schwamborn, Jens
Institute of Cell Biology
Viel, Thomas
European Institute of Molecular Imaging (EIMI)
Vrachimis, Alexis
Clinic for Nuclear Medicine
European Institute of Molecular Imaging (EIMI)
Wachsmuth, Lydia
Clinic of Radiology